This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Cramer: The Experts Make a Monster Mistake

NEW YORK (Real Money) -- Sometimes Wall Street research can be so worthless. Honestly, one month ago I recommended that people buy Monster Beverage (MNST - Get Report), suggesting that Coca-Cola (KO - Get Report) would be interested in the company and that the business was doing quite well, better than people thought. Almost immediately, Morgan Stanley and UBS both downgraded it, casting doubt on both the business and the speculation that I had made so much of.

Instantly, the stock got hammered, and I redoubled my efforts and sourced it through again and checked my contacts, and they still said I was spot on. And I thought to myself, what the heck do these analysts know that I don't?

I was racking my brains earlier this week, trying to think where I went so wrong.

I wasn't wrong at all. They were. They were clueless. Coca-Cola is all over this one, not unlike the way they were all over Green Mountain Coffee Roasters, now known as Keurig Green Mountain (GMCR), another stock that all the smart guys said was in big trouble.

Must Read: Stocks Warren Buffett Is Selling in 2014

Frankly, I think these analysts who downgraded it have to explain their work the way I have to explain why I think I am right and didn't back down but said that they were wrong at the time.

Now I know nothing will happen. They will fight the Coca-Cola news and say it is nothing in the same way the people who hated Green Mountain -- not Keurig -- stayed hating it until they were pretty much rendered moot. Or they will quietly upgrade it back if the stock slips down on some sort of geopolitical tension.

Somehow, though, there has to be a little more accountability to the system. Instead, there's none.

Just doesn't seem right, but it's never been right, so I guess it's just grousing. I sure as heck though hoped you listened to me, not them. And when I get it wrong, I own it, as you know here, because I have called myself out many at time when others simply refuse to admit they ever get anything wrong .

Random musings: Congrats to a couple of hot hands, Bob Lang and Dan Fitzpatrick, for nailing this high-growth and biotech rally and J.C. Penney (JCP), respectively. Nice work, gentlemen!

At the time of publication, Action Alerts PLUS, which Cramer co-manages as a charitable trust, had no positions in the securities mentioned.

Editor's Note: This article was originally published at 7:23 p.m. EDT on Real Money on Aug. 14.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Our Tweets

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs